Showing results (251-260 of 1,387) with videos related to
Sort By:
Pageof 139
Current Cancer Drug Targets|April 1, 2017
Immunomodulatory Activity of MicroRNAs: Potential Implications for Multiple Myeloma TreatmentCirino Botta, Maria Cuce, Daniele Caracciolo, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|August 3, 2021
Iron Binding in the Ferroxidase Site of Human Mitochondrial FerritinSilvia Ciambellotti, Alessandro Pratesi, Giusy Tassone, et al.Frontiers in Endocrinology|May 6, 2021
Diabetes and Bone Involvement in Primary Hyperparathyroidism: Literature Review and Our Personal ExperienceElena Castellano, Roberto Attanasio, Alberto Boriano, et al.Studies in Health Technology and Informatics|June 30, 2021
Evaluation of plantar pressures and center of pressure trajectories in Adolescent Idiopathic ScoliosisJ Horng, X C Liu, J Thometz, et al.Human Molecular Genetics|January 15, 2004
Redistribution of transcription start sites within the FMR1 promoter region with expansion of the downstream CGG-repeat elementAlexandra Beilina, Flora Tassone, Philip H Schwartz, et al.Journal of Neural Transmission. Supplementum|February 10, 2000
Gene expression relevant to Down syndrome: problems and approachesF Tassone, R Lucas, D Slavov, et al.Journal of Hepatology|December 1, 1994
Prevalence of lupus anticoagulant in patients with cirrhosis: relationship with beta-2-glycoprotein I plasma levelsC Quintarelli, D Ferro, G Valesini, et al.Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|September 11, 2017
Altered expression of the FMR1 splicing variants landscape in premutation carriersElizabeth Tseng, Hiu-Tung Tang, Reem Rafik AlOlaby, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2006
Targeting Raf-kinase: molecular rationales and translational issuesM Caraglia, P Tassone, M Marra, et al.Pharmacological Research|October 2, 2010
Antidepressant hyperforin up-regulates VEGF in CNS tumour cellsEvelyne Tassone, Claudio Maran, Valentina Masola, et al.Pageof 139